Gastroenterology
Volume 134, Issue 1 , Pages 29-38 , January 2008

Aspirin and Folic Acid for the Prevention of Recurrent Colorectal Adenomas

  • Richard F.A. Logan

      Affiliations

    • Division of Epidemiology and Public Health, University of Nottingham, University Hospital, Nottingham, United Kingdom
    • Corresponding Author InformationAddress requests for reprints to: Professor Richard F. A. Logan, Division of Epidemiology and Public Health, School of Community Health Sciences, University of Nottingham Medical School, Queen’s Medical Centre, Nottingham, United Kingdom, NG7 2UH. fax: (44) 0-115-823-0464.
    • ,
  • Matthew J. Grainge

      Affiliations

    • Division of Epidemiology and Public Health, University of Nottingham, University Hospital, Nottingham, United Kingdom
    • ,
  • Vic C. Shepherd

      Affiliations

    • Division of Epidemiology and Public Health, University of Nottingham, University Hospital, Nottingham, United Kingdom
    • ,
  • Nicholas C. Armitage

      Affiliations

    • Division of Surgery, University of Nottingham, University Hospital, Nottingham, United Kingdom
    • ,
  • Kenneth R. Muir

      Affiliations

    • Division of Epidemiology and Public Health, University of Nottingham, University Hospital, Nottingham, United Kingdom
    • ,
  • ukCAP Trial Group

      Affiliations

    • Division of Epidemiology and Public Health, University of Nottingham, University Hospital, Nottingham, United Kingdom

Received 3 July 2007 ,Accepted 27 September 2007.

References 

  1. Ferlay J, Bray F, Pisani P. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase no. 5, version 2.0. Lyon: IARCPress; 2004;
  2. Cancer Research UK. UK bowel cancer mortality. http://info.cancerresearchuk.org/cancerstats/types/bowel/mortality/?a=5441Accessed: April 23, 2007
  3. Hawk ET, Viner JL, Umar A, et al. Cancer and the cyclo-oxygenase enzyme. Am J Cancer. 2003;2:27–55
  4. Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003;348:891–899
  5. Sandler RS, Halabi S, Baron JA, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med. 2003;348:883–890
  6. Benamouzig R, Deyra J, Martin A, et al. Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology. 2003;125:328–336
  7. Benamouzig R, Deyra J, Martin A, et al. Daily soluble aspirin and prevention of colorectal adenoma recurrence four years results of the APACC trial (abstr). Gastroenterology. 2006;130:A101
  8. Gann PH, Manson JE, Glynn RJ, et al. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst. 1993;85:1220–1224
  9. Sturmer T, Glynn RJ, Lee IM, et al. Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians’ Health Study. Ann Intern Med. 1998;128:713–720
  10. Cook NR, Lee IM, Gaziano JM, et al. Low-dose aspirin in the primary prevention of cancer: the Women’s Health Study: a randomized controlled trial. JAMA. 2005;294:47–55
  11. Dube CD, Rostom A, Lewin G, et al. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. preventive services task force. Ann Intern Med. 2007;146:365–375
  12. Flossmann E, Rothwell PM. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet. 2007;369:1603–1613
  13. Chan AT, Giovannucci EL, Meyerhardt JA, et al. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA. 2005;294:914–923
  14. Kim YI. Folate and carcinogenesis: evidence, mechanisms and implications. J Nutr Biochem. 1999;10:66–88
  15. Choi SW, Mason JB. Folate status: effects on pathways of colorectal carcinogenesis. J Nutr. 2002;132:2413S–2418S
  16. Sanjoaquin MA, Allen N, Couto E, et al. Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer. 2005;113:825–828
  17. Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas—a randomized clinical trial. JAMA. 2007;297:2351–2359
  18. Ulrich CM, Potter JD. Folate supplementation: too much of a good thing?. Cancer Epidemiol Biomarkers Prev. 2006;15:189–193
  19. Leslie A, Carey FA, Pratt NR, et al. The colorectal adenoma-carcinoma sequence. Br J Surg. 2002;89:845–860
  20. McAlister FA, Straus SE, Sackett DL, et al. Analysis and reporting of factorial trials: a systematic review. JAMA. 2003;289:2545–2553
  21. Ferraroni M, La Vechia C, D’Avanzo B. Selected micronutrient intake and the risk of colorectal cancer. Br J Cancer. 1994;70:1150–1155
  22. Giovannucci E, Rimm EB, Hunter DJ, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med. 1995;333:609–614
  23. Hixson LJ, Fennerty MB, Sampliner RE, et al. Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointest Endosc. 1991;37:125–127
  24. Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997;112:24–28
  25. van Rijn JC, Reitsma JB, Stoker J, et al. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol. 2006;101:343–350
  26. The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006;354:1567–1577
  27. Bonaa KH, Njolstad I, Ueland PM, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006;354:1578–1588
  28. Baron JA, Sandler RS, Haile RW, et al. Folate intake, alcohol consumption, cigarette smoking, and risk of colorectal adenomas. J Natl Cancer Inst. 1998;90:57–62
  29. Giovannucci E, Rimm EB, Ascherio A, et al. Alcohol, low-methionine—low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst. 1995;87:265–273
  30. Bressler B, Paszat LF, Chen Z, et al. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology. 2007;132:96–102
  31. Robertson DJ, Greenberg ER, Beach M, et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology. 2005;129:34–41

 Supported by a grant from Cancer Research UK (formerly the Cancer Research Campaign).

PII: S0016-5085(07)01813-6

doi: 10.1053/j.gastro.2007.10.014

Gastroenterology
Volume 134, Issue 1 , Pages 29-38 , January 2008

Article Tools

* Image Usage & Resolution